Scope of the Report GLP-1 Diabetes Treatment Drugs Market by Segments Drug Type: Liraglutide Dulaglutide Exenatide Others Application: Online Pharmacy Hospital Clinic Region: North America United States Canada Mexico Europe Germany United Kingdom France Italy Spain Nordic BENELUX Rest of Europe East Asia China Japan South Korea South Asia & Pacific India ASEAN Australia & New Zealand Rest of South Asia & Pacific Latin America Brazil Chile Rest of Latin America Middle East & Africa Kingdom of Saudi Arabia Other GCC Countries Turkiye South Africa Other African Union Rest of Middle East & Africa Frequently Asked Questions How big is the GLP-1 diabetes treatment drugs market in 2025
Prescription peptides for weight loss, like GLP-1s, are an option if you and your clinician decide theyre a good fit
Common and Potential Side Effects Enhanced Digestive Issues: You may be more prone to diarrhoea, bloating, or abdominal cramping, particularly after higher-fat meals
Carbs provide the energy your body and brain need to function well, especially if youre active
Menopause and Fatigue Tiredness is a tricky symptom, because it has so many potential causes at midlife (family, work, all of it) and may show up in different waysfeeling drained, lacking motivation, or struggling with concentration and problem solving
CT-996, a once-daily oral, small molecule GLP-1 receptor agonist currently in Phase-1 trials for treating obesity in patients with and without type 2 diabetes
